Revised Response Criteria for Malignant Lymphoma

• Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas

  2023 Neuro-Oncology article Medicine CNS Lymphoma Diagnosis and Treatment Open access

  9

  citations
• Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

  2023 Blood Advances article Medicine Lymphoma Diagnosis and Treatment Open access

  37

  citations
• Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

  2022 Journal of Clinical Oncology article Medicine CNS Lymphoma Diagnosis and Treatment Open access

  131

  citations
• PET/CT in Hodgkin Lymphoma: An Update

  2022 Seminars in Nuclear Medicine article Medicine Lymphoma Diagnosis and Treatment

  37

  citations
• Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group

  2022 Leukemia & lymphoma/Leukemia and lymphoma article Medicine Chronic Lymphocytic Leukemia Research Open access

  4

  citations
• Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

  2022 Leukemia article Medicine CNS Lymphoma Diagnosis and Treatment Open access

  175

  citations
• Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial

  2021 Cancer Medicine article Medicine Lymphoma Diagnosis and Treatment Open access

  6

  citations
• Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

  2021 Blood article Medicine Cutaneous lymphoproliferative disorders research Open access cited by 1 patent

  184

  citations
• Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update

  2021 Cancer article Medicine Lymphoma Diagnosis and Treatment Open access

  30

  citations
• 18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study

  2021 European Journal of Nuclear Medicine and Molecular Imaging article Medicine Lymphoma Diagnosis and Treatment Open access

  14

  citations
• Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

  2020 Hematological Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

  28

  citations
• Neck Lymphoma

  2020 Medical radiology book-chapter Medicine Lymphoma Diagnosis and Treatment

  0

  citations

12 results